Bulletin
Investor Alert

ADC Therapeutics S.A.

NYS: ADCT

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 12, 2022, 7:57 p.m.

/zigman2/quotes/214411413/composite

$

10.30

Change

0.00 0.00%

Volume

Volume 3,344

Quotes are delayed by 20 min

/zigman2/quotes/214411413/composite

Previous close

$ 8.12

$ 10.30

Change

+2.18 +26.85%

Day low

Day high

$8.20

$10.30

Open

52 week low

52 week high

$5.52

$32.00

Open

Annual Financials for ADC Therapeutics S.A.

Operating Activities

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Net Income before Extraordinaries (89.86M)(123.1M)(116.48M)(246.29M)(230.03M)
Depreciation, Depletion & Amortization 341,000513,0001.65M1.97M2.63M
Depreciation and Depletion 328,000976,0001.62M1.93M2.5M
Amortization of Intangible Assets 13,00025,00030,00047,000129,000
Deferred Taxes & Investment Tax Credit ----(26.05M)
Deferred Taxes ----(26.05M)
Investment Tax Credit -----
Other Funds 1.06M740,0001.14M63.23M40.56M
Funds from Operations (88.46M)(121.84M)(113.7M)(181.09M)(212.89M)
Extraordinaries -----
Changes in Working Capital 13.51M481,000(7.88M)12.36M(20.49M)
Receivables 4.82M895,000192,000-(30.22M)
Accounts Payable 5.47M(858,000)(3.43M)1.92M6.8M
Other Assets/Liabilities 3.22M444,000(4.65M)10.44M5.95M
Net Operating Cash Flow (74.95M)(121.36M)(121.58M)(168.73M)(233.38M)

Investing Activities

20172018201920202021 5-year trend
Capital Expenditures (3.16M)(2.47M)(2.15M)(2.81M)(6.38M)
Capital Expenditures (Fixed Assets) (656,000)(944,000)(358,000)(801,000)(3.43M)
Capital Expenditures (Other Assets) (2.5M)(1.53M)(1.79M)(2.01M)(2.95M)
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses -----
Purchase/Sale of Investments -----
Purchase of Investments -----
Sale/Maturity of Investments -----
Other Uses (92,000)(36,000)(100,000)(19,000)(297,000)
Other Sources -----
Net Investing Cash Flow (3.25M)(2.51M)(2.25M)(2.83M)(6.67M)

Financing Activities

20172018201920202021 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock 197.24M(24,000)101.51M433.21M778,000
Repurchase of Common & Preferred Stk. -(24,000)(141,000)--
Sale of Common & Preferred Stock 197.24M-101.66M433.21M778,000
Proceeds from Stock Options 197.24M-101.66M433.16M-
Other Proceeds from Sale of Stock ---54,000778,000
Issuance/Reduction of Debt, Net ---62.9M49.59M
Change in Current Debt -----
Change in Long-Term Debt -----
Issuance of Long-Term Debt -----
Reduction in Long-Term Debt -----
Other Funds ----218M
Other Uses -----
Other Sources ----218M
Net Financing Cash Flow 197.24M(24,000)100.51M494.97M267.39M
Exchange Rate Effect 37,000(53,000)61,000235,0006,000
Miscellaneous Funds -----
Net Change in Cash 119.08M(123.95M)(23.26M)323.64M27.35M
Free Cash Flow (75.6M)(122.31M)(121.94M)(169.53M)(236.81M)
Link to MarketWatch's Slice.